Monkeypox is a rare viral zoonotic disease caused by the monkeypox virus, which belongs to the Orthopoxvirus genus, the same group of viruses that includes smallpox. The disease was first identified in laboratory monkeys in 1958, which led to its name, though it is primarily transmitted to humans from rodents and other small mammals. Human cases of monkeypox were first documented in 1970 in the Democratic Republic of Congo (DRC), and since then, the virus has been largely confined to Central and West Africa, where it is considered endemic in several countries.
Monkeypox symptoms typically begin with fever, headache, muscle aches, and swollen lymph nodes, followed by a characteristic rash that progresses to fluid-filled sores or pustules. The disease usually lasts 2 to 4 weeks and can cause severe complications, especially in immunocompromised individuals. While monkeypox is generally less severe than smallpox, it can still lead to significant illness and, in rare cases, death.
In recent years, there has been a noticeable increase in monkeypox outbreaks, particularly in Central and West Africa. Countries like Nigeria, the Democratic Republic of Congo, and Cameroon have reported numerous cases, some of which have been linked to international travel, leading to concerns about the virus spreading beyond its traditional endemic regions. Factors contributing to these outbreaks include deforestation, increasing human-wildlife interactions, and weakened healthcare systems. The ongoing outbreaks highlight the need for enhanced surveillance, public health interventions, and research to better understand and control the spread of monkeypox. As the world continues to grapple with other global health challenges, the resurgence of monkeypox in Africa serves as a reminder of the ongoing risks posed by zoonotic diseases and the importance of preparedness and response efforts. So no it does not turn you black.